Lung Injury Prediction Score (LIPS)
Lung Injury Prediction Score (LIPS) identifies patients at risk for developing Acute Lung Injury (ALI) / ARDS early in the hospital course (before ALI is established). Enables early preventive strategies (lung-protective ventilation, restrictive fluid strategy, avoidance of blood products). Validated by Gajic et al. 2011 in 5,584 patients. Score above 4 = high risk (ALI development rate 18% vs 3% for low risk).
Score interpretation
LIPS at or below 4 -- lower risk of developing ALI/ARDS
→ Standard care; if mechanically ventilated: use lung-protective ventilation (TV 6-8 mL/kg predicted body weight) prophylactically regardless of LIPS; conservative fluid strategy where clinically safe; avoid unnecessary blood transfusions; minimize sedation; early enteral nutrition; head of bed at 30-45 degrees; reassess daily.
LIPS above 4 -- high risk of ALI/ARDS; implement preventive strategies
→ Intensivist awareness and proactive prevention: (1) Lung-protective ventilation from the outset if intubated -- TV 6 mL/kg predicted body weight, plateau pressure below 30 cmH2O, PEEP 5-8 cmH2O; (2) Restrictive fluid strategy (target zero fluid balance or slight negative balance); (3) Minimise blood product use (threshold for RBC below 70 g/L, FFP only for active bleeding/coagulopathy); (4) Avoid gastric over-distension and aspiration risk; (5) Treat underlying cause urgently (antibiotics, source control); (6) Consider HFNC if not intubated and SpO2 borderline; monitor P/F ratio and bilateral CXR daily; if Berlin ARDS criteria met: full ARDS protocol.
Interpretation bands for the LIPS Score. Apply clinical judgement and local guidance.
References
- Gajic O et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med. 2011;183(4):462-470.
- ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533.
Related
Curated clinical cross-links plus same-class fallbacks.
- Dexamethasone (ICU / ARDS) · Systemic Corticosteroid
- Thiamine (IV/IM — Pabrinex) · Vitamin B1 (Thiamine) — deficiency treatment / Wernicke's encephalopathy prevention
- Anthrax Vaccine · Vaccine (Bacterial — Anthrax Prevention)
- Edoxaban (AF Stroke Prevention / VTE) · Direct Factor Xa Inhibitor (DOAC)
- Valganciclovir · Prodrug Antiviral — CMV Prevention and Treatment (Oral)
- Valaciclovir · Prodrug Antiviral — HSV / VZV / CMV Prevention (Oral)
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.